Loss of p21 does not protect against premature ovarian insufficiency caused by alkylating agents [PDF]
Frontiers in EndocrinologyBackgroundRecent studies have focused on investigating the role of cellular senescence in ovarian aging. Targeting cellular senescence has been proposed as a potential strategy to improve ovarian aging.
Xiaohui Lu +8 more
doaj +2 more sources
Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents [PDF]
Neoplasia: An International Journal for Oncology ResearchThe ADP-ribosyl hydrolases PARG and ARH3 counteract PARP enzymatic activity by removing ADP-ribosylation. PARG and ARH3 activities have a synthetic lethal effect; however, the specific molecular mechanisms underlying this response remain unknown.
Rocco Caggiano +12 more
doaj +2 more sources
In Situ Evaluation of the GSH Depletion Ability of Various Alkylating Agents and the Protective Effect of Several Active Thiol Compounds Based on High-Content Cell Analysis [PDF]
ToxicsThe depletion degree of reduced glutathione is a critical indicator for assessing the toxicity of alkylating agents. In the present research, we have developed a novel method to evaluate the glutathione (GSH) depletion induced by a series of alkylating ...
Jing Guo +7 more
doaj +2 more sources
Non‐alkylating agents‐induced gonadotoxicity in pre‐pubertal males: Insights on the clinical and pre‐clinical front [PDF]
Clinical and Translational ScienceWhilst chemotherapy regimens have proven to be more successful for pediatric cancer patients over the years, their influence on long‐term side effects is relatively poorly understood.
Sruthi Sriram +4 more
doaj +2 more sources
Novel Pathways of Oxidative and Nitrosative Inactivation of the Human MGMT Protein in Colon Cancer and Glioblastoma Cells: Increased Efficacy of Alkylating Agents In Vitro and In Vivo [PDF]
DiseasesBackground: O6-Methylguanine-DNA methyltransferase (MGMT) is a unique antimutagenic DNA repair protein that plays a crucial role in conferring resistance to various alkylating agents in brain tumor therapy.
Debasish Basak +3 more
doaj +2 more sources
Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer [PDF]
Frontiers in Oncology, 2022 Exposure to alkylating agents and radiation may cause damage and apoptosis in cancer cells. Meanwhile, this exposure involves resistance and leads to metabolic reprogramming to benefit cancer cells.
Yu-Chan Chang +10 more
doaj +2 more sources
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy [PDF]
Biomedicines, 2019 The alkylating agent temozolomide (TMZ) together with maximal safe bulk resection and focal radiotherapy comprises the standard treatment for glioblastoma (GB), a particularly aggressive and lethal primary brain tumor.
Hannah Strobel +7 more
doaj +2 more sources
Polyphenols enhance the activity of alkylating agents in leukaemia cell lines. [PDF]
Oncotarget, 2019 Polyphenols have been shown to sensitize solid tumours to alkylating agents such as cisplatin, and induce apoptosis and/or cell-cycle arrest. Here, we assess the effects of five polyphenols alone and in combination with three alkylating agents: cisplatin,
Mahbub AA +4 more
europepmc +3 more sources
Alkylating Agents Stronger than Alkyl Triflates [PDF]
Journal of the American Chemical Society, 2004 A new class of potent electrophilic "R(+)" alkylating agents has been developed using weakly nucleophilic carborane anions as leaving groups. These reagents, R(CHB(11)Me(5)X(6)) (R = Me, Et, and i-Pr; X = Cl, Br), are prepared via metathesis reactions with conventional alkylating agents such as alkyl triflates, using the high oxophilicity of silylium ...
Kato, Tsuyoshi +4 more
openaire +4 more sources
MPTAC links alkylation damage signaling to sterol biosynthesis
Redox Biology, 2022 Overproduction of reactive oxygen species (ROS) drives inflammation and mutagenesis. However, the role of the DNA damage response in immune responses remains largely unknown.
Tamaki Suganuma, Jerry L. Workman
doaj +1 more source